The NLRP3 inflammasome in fibrosis and aging: The known unknowns

Ageing Res Rev. 2022 Aug:79:101638. doi: 10.1016/j.arr.2022.101638. Epub 2022 May 5.

Abstract

Aging-related diseases such as cancer, cardiovascular diseases, diabetes, and neurodegenerative diseases are often accompanied by fibrosis. The NLRP3 inflammasome triggers the inflammatory response and subsequently promotes fibrosis through pathogen-associated molecular patterns (PAMPs). In this review, we first introduce the general background and specific mechanism of NLRP3 in fibrosis. Second, we investigate the role of NLRP3 in fibrosis in different organs/tissues. Third, we discuss the relationship between NLRP3 and fibrosis during aging. In summary, this review describes the latest progress on the roles of NLRP3 in fibrosis and aging and reveals the possibility of NLRP3 as an antifibrotic and anti-aging treatment target.

Keywords: Aging; Fibrosis; NLRP3.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging* / pathology
  • Fibrosis* / metabolism
  • Fibrosis* / prevention & control
  • Humans
  • Inflammasomes* / metabolism
  • NLR Family, Pyrin Domain-Containing 3 Protein* / metabolism

Substances

  • Inflammasomes
  • NLR Family, Pyrin Domain-Containing 3 Protein